fingolimod hydrochloride has been researched along with sr1001 in 1 studies
Studies (fingolimod hydrochloride) | Trials (fingolimod hydrochloride) | Recent Studies (post-2010) (fingolimod hydrochloride) | Studies (sr1001) | Trials (sr1001) | Recent Studies (post-2010) (sr1001) |
---|---|---|---|---|---|
2,771 | 157 | 2,062 | 22 | 0 | 22 |
Protein | Taxonomy | fingolimod hydrochloride (IC50) | sr1001 (IC50) |
---|---|---|---|
Nuclear receptor ROR-gamma | Homo sapiens (human) | 2 |
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 0 (0.00) | 18.2507 |
2000's | 0 (0.00) | 29.6817 |
2010's | 1 (100.00) | 24.3611 |
2020's | 0 (0.00) | 2.80 |
Authors | Studies |
---|---|
Kulkarni, P; Medishetti, R; Saxena, U; Sriram, D; Yellanki, S; Yogeeswari, P | 1 |
1 other study(ies) available for fingolimod hydrochloride and sr1001
Article | Year |
---|---|
Novel Zebrafish EAE model: A quick in vivo screen for multiple sclerosis.
Topics: Animals; Dexamethasone; Dimethyl Fumarate; Drug Evaluation, Preclinical; Encephalomyelitis, Autoimmune, Experimental; Fingolimod Hydrochloride; Immunologic Factors; Phenotype; Sulfonamides; Thiazoles; Video Recording; Zebrafish | 2017 |